健脾益肾颗粒减轻528例肿瘤患者化疗毒副作用的临床观察  

Clinical Observation of Jianpi Yishen Granule in the Relief for Toxic and Negative Effects of Chemotherapy in Treating 528 Cases of Cancer

作　　者：董海涛[1] 刘浩[1] 关念波[1] 赵炜[1] 卢雯平[1] 陈丽珠[1] 

机构地区：[1]中国中医科学院广安门医院肿瘤科,北京100053

出　　处：《中国中医药信息杂志》2008年第9期12-13,共2页Chinese Journal of Information on Traditional Chinese Medicine

摘　　要：目的观察健脾益肾颗粒减轻化疗毒副作用的临床疗效。方法将528例肿瘤患者随机分为健脾益肾联合化疗组(治疗组265例)和单用化疗组(对照组263例)。治疗组化疗时加服健脾益肾颗粒,对照组单用化疗,2组均连续化疗2个周期。观察2组有效率、治疗前后卡氏评分和免疫功能的变化及不良反应。结果治疗组总有效率(CR+PR)为61.4%、对照组为60.5%,2组治疗后卡氏评分相比差异有统计学意义(P<0.01),免疫功能疗后治疗组与对照组其NK细胞活性、CD3+(%)、CD4+(%)、CD8+(%)、CD4+/CD8+差异有统计学意义(P<0.05,P<0.01),治疗组不良反应发生率显著低于对照组(P<0.01)。结论健脾益肾颗粒能明显减轻化疗毒性,改善免疫功能,提高化疗疗效和患者生活质量。Objective To observe the clinical effects of Jianpi Yishen granule in the relief for toxic and negative effects of chemotherapy in treating cancer. Methods Five hundred and twenty eight cases were randomized into two groups： the treatment group in which Jianpi Yishen granule and chemotherapy were used and the control group in which chemotherapy only was given. Total two cycles were performed for two groups. The effective rate, the changes of Kamofsky scores and immunity, the adverse reaction to chemotherapy in the two groups were observed before and after the treatment. Results The effective rate （CR＋PR） in the treatment group and the control group was 61.4% and 60.5% respectively, and the improvement in Kamofsky scores in the fomer was higher than in the latter （P〈0.01）. The T lymphocyte subsets and NK cells in the treatment group were elevated compared with those in the control group, and the differences were significant （P〈0.05）. The adverse reaction in blood were all lower in the treatment group than those in the control group （P〈0.01）. Conclusion Jianpi Yishen granule can relieve the toxic and negative effects due to chemotherapy and boost the immunity. It can enhance clinical efficacy and improve the quality of life.

关 键 词：健脾益肾颗粒 肿瘤 化疗 毒副作用 

分 类 号：R273[医药卫生—中西医结合]